AstraZeneca plc (ADR) (NYSE:AZN)

CAPS Rating: 5 out of 5

The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

Recs

0
Player Avatar cwpicks (64.01) Submitted: 5/10/2011 4:13:51 PM : Outperform Start Price: $48.36 AZN Score: -11.93

@51.35

Featured Broker Partners


Advertisement